QSAM Biosciences, Inc.
QSAM · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,386 | $225 | $1,500 | $8 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $319 | $139 | $135 | $13 |
| Total Curr. Assets | $1,705 | $365 | $1,670 | $21 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $25 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $35 | $0 |
| Total NC Assets | $0 | $0 | $35 | $25 |
| Other Assets | $0 | $0 | -$35 | -$25 |
| Total Assets | $1,705 | $365 | $1,670 | $21 |
| Liabilities | – | – | – | – |
| Payables | $570 | $745 | $569 | $308 |
| Short-Term Debt | $8 | $451 | $43 | $3,348 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | -$1,025,398,544 | $0 | $0 | $0 |
| Other Curr. Liab. | $456 | $384 | $781 | $533 |
| Total Curr. Liab. | $1,033 | $1,580 | $1,393 | $4,190 |
| LT Debt | $0 | $0 | $532 | $109 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | -$532 | $0 |
| Total NC Liab. | $1,000 | $1,196 | $532 | $109 |
| Other Liabilities | -$1,000 | -$1,196 | -$532 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,033 | $1,580 | $1,393 | $4,299 |
| Equity | – | – | – | – |
| Pref Stock | $509 | $721 | $694 | $784 |
| Common Stock | $0 | $0 | $7 | $2 |
| Retained Earnings | -$40,159 | -$35,178 | -$29,282 | -$15,912 |
| AOCI | -$1,346 | -$187 | -$901 | -$148 |
| Other Equity | $41,667 | $33,428 | $29,759 | $10,997 |
| Total Equity | $672 | -$1,215 | $277 | -$4,277 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,705 | $365 | $1,670 | $21 |
| Net Debt | -$1,379 | $226 | -$925 | $3,449 |